The historically stagnant pharmacologic landscape for systemic lupus erythematosus (SLE) is currently poised for rapid expansion – offering clinicians unprecedented opportunity to employ personalized treatment approaches with targeted agents.Tune in to this recording from a previous live TheraTalk webinar where two renowned rheumatologists take a deep dive into the: Far-reaching impacts of life with SLECurrent understanding of SLE pathophysiologyExciting therapeutic developments underway, including an in-depth review of the latest clinical trial data for novel targeted SLE agents and their potential impact on practice.This program features video-based patient testimonials and two 3D medical animations which provide a close-up view of the multi-organ nature of SLE and allow you to visualize the key mechanisms of action for emerging treatments.You also have access to a downloadable FAQs resource which highlights the most crucial information as determined by you and your fellow learners through questions submitted upon event registration.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedSep 16, 2026
-
Last day to claim creditSep 16, 2027 11 months left
-
AchieveCE Systemic Lupus Erythematosus: Diagnosis and Management Across the Lifespan
-
Medscape, LLC Advances in Systemic Lupus Erythematosus: From Guideline Updates to Emerging Therapeutic Targets
-
Postgraduate Healthcare Education, LLC +1 Expanding the Therapeutic Landscape for Systemic Lupus Erythematosus and Lupus Nephritis: Moving into an Era of Targeted Therapy and Collaborative Care
-
PRIME Education, Inc. (PRIME®) Exploring Mechanisms of Action of Emerging Targeted Therapies for Systemic Lupus Erythematosus: An Interactive 3D Animation
-
PRIME Education, Inc. (PRIME®) Examining Key Organs Impacted by Systemic Lupus Erythematosus: An Interactive 3D Animation
-
PRIME Education, Inc. (PRIME®) Exploring Underlying Pathogenesis in Sjögren’s Disease and a Rapidly Expanding Therapeutic Landscape
